.png)
.png)
Global Health Challenges
Meta-Platform
Global Health Challenges Meta-Platform gather such challenges as Lyme disease, autism, Alzheimer's, diabetes, oncology, Neuro Covid, infertility issues, kids' health, chronic fatigue, burn out, vaccines' consequences, green & wellness issues, em-pollution, bad bugs, forever toxins and many others. At Deep Knowledge Group and Longevity Industry Analytics, we possess the deep knowledge required to address these complex issues and their far-reaching health consequences. Our mission is clear: to mitigate these Global Health Challenges and prevent their lasting impact on human health.
Our extensive expertise in these fields, combined with our cutting-edge clinics, uniquely positions us to combat these pressing issues. We are actively seeking investors and partners to join us in revolutionizing the approach to tackling these global health challenges. Together, we can make a significant impact on the management of these critical health issues and pave the way for a healthier future.
Interactive GeoMap GHC
Prevalence by % Population
Global Perspective
Global health challenges encompass a broad range of issues, including Lyme disease, autism, Alzheimer’s, diabetes, and more. Recent studies indicate that most of individuals worldwide are affected by several of these conditions, which have significant implications for public health. Understanding the factors influencing the prevalence of these diseases is crucial for their effective prevention, diagnosis, and management.
Many people grapple with the consequences of these health challenges, experiencing persistent symptoms and compromised quality of life. Conditions such as chronic fatigue, neuro Covid, and electromagnetic pollution further exacerbate these issues, provoking and accelerating the development of age-related diseases. Addressing these complex problems requires a multifaceted approach, emphasizing their connection to aging.
Source: Longevity Industry Analytics
The global perspective on health challenges extends beyond research, involving collaborative efforts to raise awareness and foster understanding. Analytical groups, healthcare and government organizations, and affected communities worldwide are joining forces to shed light on the complexities posed by conditions such as autism, Alzheimer’s, diabetes, and more.
GHC Ecosystem
CHG GeoDashboard
69 000+
Clinic Trials
10 000+
Companies
5000+
Investors
250 000+
Data Points
Global Health Challenges Market in Charts
Anticipated to show remarkable progress, the Global Health Challenges treatment market is poised to surge from USD 1890 Billion in 2021 to USD 5170 Billion in 2032, marking an impressive Compound Annual Growth Rate of around 9.6%. The market's rapid growth is propelled by various critical factors. These include rising Global Health Challenges disease cases, significant investments from major healthcare providers, advancements in healthcare infrastructure, and the introduction of precise diagnostic methods. These elements combine synergistically to drive and maintain market expansion consistently. This trend reflects increasing and enduring demand for enhanced treatments and diagnostic solutions addressing Global Health Challenges.
Solutions for GHC
The Lyme Pandemic and other Global Health Challenges pose a significant challenge, with a growing pharmaceutical market each year. Despite this expansion, the issue persists, highlighting the complexity and difficulty in finding a comprehensive resolution to the problems.
At DKG, we frequently encounter people facing challenges in managing their symptoms after undergoing conventional therapy. Drawing on over a decade of analytical expertise, we have accumulated and explored advanced holistic methods to effectively impact on the spread of Global Health Challenges prevalence in the World. Comprehensive diagnostics, advanced and timely treatments are vital, while untreated cases may lead to potential physical or psychological impairment.
Our proficiency in dealing with Global Health Challenges revolves around personalized proprietary treatments that integrate cutting-edge and natural therapies related to Mitochondrial, Space, Restorative, Functional Medicine within the framework of Longevity Medicine.
Hyperbaric Oxygen Therapy
Intermittent Hypoxia–Hyperoxia Training
Plasmapheresis
Intervention
Keto and Carnivorous Diets
GHC Dashboard
Global Health Challenges Dashboard is a centralized hub designed to meet all the market and business intelligence needs of its users. It offers comprehensive support, encompassing benchmarking for companies, technologies, and thorough competitive and SWOT analysis for over 69 000 clinical trials, 10 000 companies, 5000 investors, and a staggering 250,000 data inputs within the Global Health Challenges sector.
Interactive GeoMap GHC Clinical Trials
Source: Longevity Industry Analytics
The United States stands as the primary research center for GHC studies, hosting over 35% of these clinical trials.
UK spearheads the European contribution with nearly 6% of clinical trials, followed by approximately 4% in France. Combined, European nations contribute to more than 25% of these trials.
China is a significant player in Asia, conducting close to 6% of the global clinical trials, demonstrating its growing commitment to medical research and innovation. Similarly, Japan contributes about 2% to the global clinical trial efforts, highlighting its strong research infrastructure.
In the Middle East, Israel leads with around 2% of the trials, showcasing its advanced research capabilities. Other countries, such as Saudi Arabia and the United Arab Emirates, are also making notable contributions, collectively accounting for approximately 1% of the global total. Egypt is a significant player with about 2.5% of the global clinical trials efforts.
Lyme Disease may Trigger Cancer
Untreated Lyme infections can have serious consequences, such as extended hospitalization, chronic symptoms, and in some instances, the onset of autoimmune disorders and cancers. Clinical research* suggests that the bacteria B. burgdorferi, associated with Lyme, may contribute to the development of cancers. Obtaining an accurate diagnosis and comprehensive treatment is essential to avoid these severe outcomes.
*Smith, A. , Oertle, J. and Prato, D. (2014) Cancer and Infectious Causes. Open Journal of Medical Microbiology, 4, 161-177. doi: 10.4236/ojmm.2014.43019.
Global Medical Clinics Dashboard
GMC Big Data Analytics Dashboard serves as a one-stop-platform for all market and business intelligence operations its customers may need, including benchmarking for companies, technologies, competitive and SWOT analysis for more than 5000+ medical clinics.
The Dashboard aggregates data from about 12,000+ medicine companies divided into 8 main categories and distributed across various locations. Based on this data, Dashboard provides users with tools for conducting market intelligence, analysing the industry trends and delivering insights from analytics.
Longevity Industry Analytics – Powered by Deep Knowledge Group
Longevity Industry Analytics is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.
.png)
